Haim Belmaker  Prof. Robert Haim Belmaker (, born 8 July 1947), is an Israeli psychiatrist who has had major academic positions in Israeli psychiatry since 1974. He had a formative influence on biological directions in Israeli psychiatry. He was Hoffer-Vickar Professor of Psychiatry at Ben-Gurion University of the Negev, Beersheva Israel (holding the first named Chair of Psychiatry in Israel) until his retirement and is now Emeritus. He was President of the International College of Neuropsychopharmacology 2008–2010, President of the Israel Psychiatry Association 2015–2018, and Organizing Chair of the World Psychiatric Association Congress on Psychiatry and Religion held in Jerusalem, Israel in December 2019 He has contributed editorials in the areas of treatment of bipolar disorder in 2007 and then in 2014 on antipsychotic treatment of bipolar disorder, on the potential of transcranial magnetic stimulation as a new frontier (1995) and on the future of randomised clinical trials (2015). An oral history of his research contributions is available at the American College of Neuropsychopharmacology video archives  Prof. Belmaker received his BA from Harvard College in 1967; his MD from Duke Medical School in 1971; and was a Clinical Fellow at US National Institute of Mental Health 1972–1974. Belmaker has researched the mechanism of action of lithium in bipolar disorder throughout his career and focussed interest on second messenger systems in the brain, Biological Psychiatry, 1993, New England Journal of Medicine, (2007). He was one of the first psychiatrists to study a continuum between the molecular genetics of temperament and that of bipolar disorder and edited a seminal volume. He was one of the first investigators to see the potential for transcranial magnetic stimulation of the brain as a treatment for depression, the first to study it in animal models of depression, and co-edited the first handbook of this treatment for psychiatric disorder that was widely influential for many years. President of the International College of Neuropsychopharmacology (CINP) 2008–2010 2. Vice-President of the International Society for Bipolar Disorders (ISBD) 2012–2014 3. President of the Israel Psychiatric Association 2015–2018 4. President of the International Neuropsychiatry Association 2016–2018 5. Deputy Director of the Mental Health Center in Beersheba 1994–2012  "(Partial List)"    He has received the Anna Monika Prize for Research in Depression (1983), the Ziskind-Somerfeld Prize for Senior Research in Psychiatry (1993) and the European College of Neuropsychopharmacology Lilly Research Award (1996), and the National Alliance for Research on Schizophrenia and Depression Lifetime Achievement Nola Maddox Falcone Prize for research in affective disorder (2000), and the research prize of the World Federation of Societies of Biological Psychiatry (2004).